IWV

BlackRock Institutional Trust Company N.A. - iShares Russell 3000 ETF

Jackson added that he was long on the stock, while highlighting that the biotech company’s balance sheet is solid.

The company reported that a lower hospitalization rate was observed in patients treated with Zelicapavir compared to those treated with placebo, and the drug demonstrated a robust antiviral effect.

The company said that anaphylaxis or a severe allergic reaction was reported in seven participants in the open-label study evaluating Nomlabofusp in participants with Friedreich’s ataxia.

The acquisition will include Melt’s lead investigational therapy, MELT-300, designed to provide rapid, predictable sedation and analgesia without the need for intravenous administration.

Rambus’ technology and IP is central to the artificial intelligence-driven performance increase in data centers, said Baird analyst Tristan Gerra.

Price-sensitive consumers and a lack of big promotional drive dampen outlook for Bath & Body Works’ third quarter, Citi said.

Anavex' once-daily drug candidate demonstrated pre-specified clinical efficacy in people with early Alzheimer’s disease.

Under U.S. law, telehealth platforms are only allowed to manufacture copycat weight-loss drugs when the branded originals are in short supply.